- Home
- STTK vs APWC Comparison
STTK vs APWC Comparison
Compare STTK & APWC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STTK
- APWC
- Stock Information
- Founded
- STTK 2016
- APWC 1996
- Country
- STTK United States
- APWC Taiwan
- Employees
- STTK N/A
- APWC N/A
- Industry
- STTK Biotechnology: Pharmaceutical Preparations
- APWC Telecommunications Equipment
- Sector
- STTK Health Care
- APWC Industrials
- Exchange
- STTK Nasdaq
- APWC Nasdaq
- Market Cap
- STTK 37.6M
- APWC 34.6M
- IPO Year
- STTK 2020
- APWC 1997
- Fundamental
- Price
- STTK $0.83
- APWC $1.69
- Analyst Decision
- STTK Hold
- APWC
- Analyst Count
- STTK 4
- APWC 0
- Target Price
- STTK $3.00
- APWC N/A
- AVG Volume (30 Days)
- STTK 401.8K
- APWC 9.4K
- Earning Date
- STTK 07-31-2025
- APWC 08-25-2025
- Dividend Yield
- STTK N/A
- APWC N/A
- EPS Growth
- STTK N/A
- APWC N/A
- EPS
- STTK N/A
- APWC 0.17
- Revenue
- STTK $4,606,000.00
- APWC $472,672,000.00
- Revenue This Year
- STTK N/A
- APWC N/A
- Revenue Next Year
- STTK N/A
- APWC N/A
- P/E Ratio
- STTK N/A
- APWC $9.94
- Revenue Growth
- STTK 69.65
- APWC 11.02
- 52 Week Low
- STTK $0.69
- APWC $1.36
- 52 Week High
- STTK $4.99
- APWC $2.02
- Technical
- Relative Strength Index (RSI)
- STTK 39.19
- APWC 53.49
- Support Level
- STTK $0.77
- APWC $1.65
- Resistance Level
- STTK $0.91
- APWC $1.73
- Average True Range (ATR)
- STTK 0.08
- APWC 0.06
- MACD
- STTK -0.02
- APWC -0.00
- Stochastic Oscillator
- STTK 16.23
- APWC 57.14
About STTK Shattuck Labs Inc.
Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.
About APWC Asia Pacific Wire & Cable Corporation Ltd. (Bermuda)
Asia Pacific Wire & Cable Corp Ltd is a holding company. It is principally engaged in the manufacture and distribution of enameled wire, power cable, and telecommunications products in Thailand, Singapore, Australia, PRC, Hong Kong and certain other markets in the Asia Pacific region. It also provides project engineering services in the supply, delivery and installation of power cables (SDI). Some of the company's products are Bare wires, Power cables, Communication cables, Electronic wires & cables, and Enamelled wires. The company's geographical segments are North Asia, Thailand, and Rest of the World.